Tyrosine modifications in aging

Antioxidants and Redox Signaling

Volumn 17, Issue 11, 2012, Pages 1571-1579

  Feeney, Maria B ^a   Schöneich, Christian ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CHLOROTYROSINE; 3 NITROTYROSINE; 3,3' DITYROSINE; 6 FLUORODOPA; DOPA; DOPAQINONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HIGH DENSITY LIPOPROTEIN; MANGANESE SUPEROXIDE DISMUTASE; TYROSINE; UNCLASSIFIED DRUG;

AGING; ATHEROGENESIS; CATALYSIS; CATARACT; CHEMICAL ANALYSIS; CHLORINATION; CONJUGATION; ENZYME ACTIVATION; HUMAN; LYSOSOME; NITRATION; OXIDATION KINETICS; PHOTOSENSITIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

AGING; ATHEROSCLEROSIS; CATARACT; HUMANS; NERVE DEGENERATION; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TYROSINE;

EID: 84866867477     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4595     Document Type: Review

References (50)

1. Abello N, Kerstjens HAM, Postma DS, and Bischoff R. Protein tyrosine nitration: Selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. J Proteome Res 8: 3222-3238, 2009.
2. Ajees AA, Anantharamaiah GM, Mishra VK, Hussain MM, and Murthy HMK. Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases. Proc Natl Acad Sci USA 103: 2126-2131, 2006. (Pubitemid 43271634)
3. Bartesaghi S, Wenzel J, Trujillo M, López M, Joseph J, Kalyanaraman B, and Radi R. Lipid peroxyl radicals mediate tyrosine dimerization and nitration in membranes. Chem Res Toxicol 23: 821-835, 2010.
4. Bergt C, Fu X, Huq NP, Kao J, and Heinecke JW. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J Biol Chem 279: 7856-7866, 2004. (Pubitemid 38294672)
5. Brennan M-L, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, and Hazen SL. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349: 1595-1604, 2003. (Pubitemid 37288567)
6. Coval ML and Taurog A. Purification and iodinating activity of hog thyroid peroxidase. J Biol Chem 242: 5510-5523, 1967.
7. Cowan-Jacob SW, Kaufmann M, Anselmo AN, Stark W, and Grü tter MG. Structure of rabbit-muscle glyceraldehyde-3-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr 59: 2218-2227, 2003. (Pubitemid 38024856)
8. Davies KJA and Shringarpure R. Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and in inflammatory neuromuscular diseases. Neurology 66: S93-S96, 2006. (Pubitemid 43739992)
9. Dean RT, Fu S, Stocker R, and Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324: 1-18, 1997. (Pubitemid 27229359)
10. Dunlop RA, Brunk UT, and Rodgers KJ. Proteins containing oxidized amino acids induce apoptosis in human monocytes. Biochem J 435: 207-216, 2011.
11. Dunlop RA, Dean RT, and Rodgers KJ. The impact of specific oxidized amino acids on protein turnover in J774 cells. Biochem J 410: 131-140, 2008. (Pubitemid 351300332)
12. Fu S, Davies MJ, Stocker R, and Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J 333: 519-525, 1998. (Pubitemid 28398516)
13. Fu S, Dean R, Southan M, and Truscott R. The hydroxyl radical in lens nuclear cataractogenesis. J Biol Chem 273: 28603-28609, 1998. (Pubitemid 28507543)
14. Gieseg SP, Simpson JA, Charlton TS, Duncan MW, and Dean RT. Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. Biochemistry 32: 4780-4786, 1993. (Pubitemid 23162033)
15. Giulivi C, Traaseth NJ, and Davies KJA. Tyrosine oxidation products: Analysis and biological relevance. Amino Acids 25: 227-232, 2003. (Pubitemid 38041261)
16. Hazen SL and Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99: 2075-2081, 1997. (Pubitemid 27203762)
17. Kanski J, Hong SJ, and Schöneich C. Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine- containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. J Biol Chem 280: 24261-24266, 2005. (Pubitemid 40884916)
18. Kurz T, Terman A, Gustafsson B, and Brunk U. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol 129: 389-406, 2008.
19. Lee S, Chen Y, Luo H, Wu AA, Wilde M, Schumacker PT, and Zhao Y. The first global screening of protein substrates bearing protein-bound 3,4-dihydroxyphenylalanine in Escherichia coli and human mitochondria. J Proteome Res 9: 5705-5714, 2010.
20. MacMillan-Crow LA, Crow JP, and Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37: 1613-1622, 1998. (Pubitemid 28093677)
21. Mizdrak J, Hains PG, Truscott RJW, Jamie JF, and Davies MJ. Tryptophan-derived ultraviolet filter compounds covalently bound to lens proteins are photosensitizers of oxidative damage. Free Radic Biol Med 44: 1108-1119, 2008.
22. Moreland J, Gramada A, Buzko O, Zhang Q, and Bourne P. The Molecular Biology Toolkit (MBT): A modular platform for developing molecular visualization applications. BMC Bioinformatics 6: 21, 2005.
23. Nelson M, Foxwell AR, Tyrer P, and Dean RT. Proteinbound 3,4-dihydroxy-phenylanine (DOPA), a redox-active product of protein oxidation, as a trigger for antioxidant defences. Int J Biochem Cell Biol 39: 879-889, 2007. (Pubitemid 46575316)
24. Nelson M, Foxwell AR, Tyrer P, and Dean RT. Radical sequestration by protein-bound 3,4-dihydroxyphenylalanine. Int J Biochem Cell Biol 42: 755-761, 2010.
25. Neumann H, Hazen JL, Weinstein J, Mehl RA, and Chin JW. Genetically encoding protein oxidative damage. J Am Chem Soc 130: 4028-4033, 2008. (Pubitemid 351429872)
26. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007. (Pubitemid 46217686)
27. Palamalai V and Miyagi M. Mechanism of glyceraldehyde-3-phosphate dehydrogenase inactivation by tyrosine nitration. Protein Sci 19: 255-262, 2010.
28. Pattison DI, Dean RT, and Davies MJ. Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. Toxicology 177: 23-37, 2002. (Pubitemid 34786242)
29. Peng D-Q, Brubaker G, Wu Z, Zheng L, Willard B, Kinter M, Hazen SL, and Smith JD. Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidasemediated loss of function. Arterioscler Thromb Vasc Biol 28: 2063-2070, 2008.
30. Peng D-Q, Wu Z, Brubaker G, Zheng L, Settle M, Gross E, KinterM, Hazen SL, and Smith JD. Tyrosinemodification is not required for myeloperoxidase- induced loss of apolipoprotein A-I functional activities. J Biol Chem 280: 33775-33784, 2005. (Pubitemid 41443096)
31. Podrez EA, Abu-Soud HM, and Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28: 1717-1725, 2000. (Pubitemid 30628658)
32. Quint P, Reutzel R, Mikulski R, McKenna R, and Silverman DN. Crystal structure of nitrated human manganese superoxide dismutase: Mechanism of inactivation. Free Radic Biol Med 40: 453-458, 2006. (Pubitemid 43139680)
33. Scaloni A. Mass spectrometry approaches for the molecular characterization of oxidatively/nitrosatively modified proteins. In: Redox Proteomics: From ProteinModifications to Cellular Dysfunction and Diseases. eds. Dalle-Donne I, Scaloni A, Butterfield DA. Hoboken, NJ:Wiley-Interscience; 2006. pp. 59-99.
34. Shao B, Bergt C, Fu X, Green P, Voss JC, Oda MN, Oram JF, and Heinecke JW. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 280: 5983-5993, 2005. (Pubitemid 40280082)
35. Shao B and Heinecke JW. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway. J Proteomics 74: 2289-2299, 2011.
36. Shao B, Oda MN, Bergt C, Fu X, Green PS, Brot N, Oram JF, and Heinecke JW. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J Biol Chem 281: 9001-9004, 2006. (Pubitemid 43864611)
37. Shao B, Tang C, Heinecke JW, and Oram JF. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. J Lipid Res 51: 1849-1858, 2010.
38. Smith JD. Dysfunctional HDL as a diagnostic and therapeutic target. Arterioscler Thromb Vasc Biol 30: 151-155, 2010.
39. Smith JD. Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein. J Clin Lipidol 4: 382-388, 2010.
40. Sokolovsky M, Riordan JF, and Vallee BL. Conversion of 3-nitrotyrosine to 3-aminotyrosine in peptides and proteins. Biochem Biophys Res Commun 27: 20-25, 1967.
41. Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 62: 797-821, 1993. (Pubitemid 23237888)
42. Stadtman ER and Levine RL. Chemical modification of proteins by reactive oxygen species. In: Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases. eds. Dalle-Donne I, Scaloni A, Butterfield DA. Hoboken, NJ: Wiley-Interscience; 2006. pp. 3-23.
43. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, and Butterfield DA. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22: 76-87, 2006.
44. Wang SX, Mure M, Medzihradszky KF, Burlingame AL, Brown DE, Dooley DM, Smith AJ, Kagan HM, and Klinman JP. A crosslinked cofactor in lysyl oxidase: Redox function for amino acid side chains. Science 273: 1078-1084, 1996.
45. Whiteman M, Chu SH, Siau JL, Rose P, Sabapathy K, Schantz J-T, Cheung NS, Spencer JPE, and Armstrong JS. The pro-inflammatory oxidant hypochlorous acid induces Bax-dependent mitochondrial permeabilisation and cell death through AIF-/EndoG-dependent pathways. Cell Signal 19: 705-714, 2007. (Pubitemid 46275363)
46. Yee CS, Seyedsayamdost MR, Chang MCY, Nocera DG, and Stubbe J. Generation of the R2 subunit of ribonucleotide reductase by intein chemistry: Insertion of 3-nitrotyrosine at residue 356 as a probe of the radical initiation process. Biochemistry 42: 14541-14552, 2003. (Pubitemid 37532001)
47. Zhang R, Brennan M-L, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, and Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286: 2136-2142, 2001. (Pubitemid 34041599)
48. Zhang X, Monroe ME, Chen B, Chin MH, Heibeck TH, Schepmoes AA, Yang F, Petritis BO, Camp DG, Pounds JG, Jacobs JM, Smith DJ, Bigelow DJ, Smith RD, and Qian W-J. Endogenous 3,4-dihydroxyphenylalanine and dopaquinone modifications on protein tyrosine: Links to mitochondrially derived oxidative stress via hydroxyl radical. Mol Cell Proteomics 9: 1199-1208, 2010.
49. Zheng L, Nukuna B, Brennan M-L, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, and Hazen SL. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114: 529-541, 2004. (Pubitemid 39572103)
50. Zheng L, Settle M, Brubaker G, Schmitt D, Hazen SL, Smith JD, and Kinter M. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J Biol Chem 280: 38-47, 2005. (Pubitemid 40164962)